These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9131489)

  • 1. In vitro techniques for studying drug metabolism.
    Guengerich FP
    J Pharmacokinet Biopharm; 1996 Oct; 24(5):521-33. PubMed ID: 9131489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of enzymes of drug metabolism.
    Meyer UA
    J Pharmacokinet Biopharm; 1996 Oct; 24(5):449-59. PubMed ID: 9131484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans.
    Wilkinson GR
    J Pharmacokinet Biopharm; 1996 Oct; 24(5):475-90. PubMed ID: 9131486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human drug metabolizing cytochromes P450.
    Wrighton SA; VandenBranden M; Ring BJ
    J Pharmacokinet Biopharm; 1996 Oct; 24(5):461-73. PubMed ID: 9131485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of metabolic drug-drug interactions: a descriptive and critical commentary.
    Li AP
    Curr Protoc Toxicol; 2007; Chapter 4():Unit 4.25. PubMed ID: 23045147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human drug metabolism and the cytochromes P450: application and relevance of in vitro models.
    Venkatakrishnan K; Von Moltke LL; Greenblatt DJ
    J Clin Pharmacol; 2001 Nov; 41(11):1149-79. PubMed ID: 11697750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic activities of cytochrome P450 enzymes and UDP-glucuronosyltransferases involved in drug metabolism in rat everted sacs and intestinal microsomes.
    Takemoto K; Yamazaki H; Tanaka Y; Nakajima M; Yokoi T
    Xenobiotica; 2003 Jan; 33(1):43-55. PubMed ID: 12519693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans.
    Mössner LD; Schmitz A; Theurillat R; Thormann W; Mevissen M
    Am J Vet Res; 2011 Nov; 72(11):1505-13. PubMed ID: 22023129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro cytochrome P450 inhibition and induction.
    Walsky RL; Boldt SE
    Curr Drug Metab; 2008 Nov; 9(9):928-39. PubMed ID: 18991590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolism of drugs. III. Genetic factors inducing and inhibiting metabolism].
    Dyderski S; Grzymisławski M
    Pol Merkur Lekarski; 2005 Apr; 18(106):457-61. PubMed ID: 16161934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studying cytochrome P450 kinetics in drug metabolism.
    Kramer MA; Tracy TS
    Expert Opin Drug Metab Toxicol; 2008 May; 4(5):591-603. PubMed ID: 18484917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic selectivity of human cytochrome P450 enzymes: relevance to drug metabolism and toxicity.
    Guengerich FP
    Toxicol Lett; 1994 Feb; 70(2):133-8. PubMed ID: 8296317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of inhibitory monoclonal antibodies to assess the contribution of cytochromes P450 to human drug metabolism.
    Shou M; Lu T; Krausz KW; Sai Y; Yang T; Korzekwa KR; Gonzalez FJ; Gelboin HV
    Eur J Pharmacol; 2000 Apr; 394(2-3):199-209. PubMed ID: 10771285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of metabolic pathways involved in the biotransformation of tolperisone by human microsomal enzymes.
    Dalmadi B; Leibinger J; Szeberényi S; Borbás T; Farkas S; Szombathelyi Z; Tihanyi K
    Drug Metab Dispos; 2003 May; 31(5):631-6. PubMed ID: 12695352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of cytochrome P450 in the metabolism of rebamipide by the human liver.
    Koyama N; Sasabe H; Miyamoto G
    Xenobiotica; 2002 Jul; 32(7):573-86. PubMed ID: 12162853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics.
    Forrester LM; Henderson CJ; Glancey MJ; Back DJ; Park BK; Ball SE; Kitteringham NR; McLaren AW; Miles JS; Skett P
    Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):359-68. PubMed ID: 1736885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibition of hepatic microsomal drug metabolism in rats by non-steroidal anti-inflammatory drugs.
    Gasperini R; Leone R; Velo GP; Fracasso ME
    Pharmacol Res; 1990; 22 Suppl 3():115-6. PubMed ID: 2097621
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-drug interactions in the metabolism of imidafenacin: role of the human cytochrome P450 enzymes and UDP-glucuronic acid transferases, and potential of imidafenacin to inhibit human cytochrome P450 enzymes.
    Kanayama N; Kanari C; Masuda Y; Ohmori S; Ooie T
    Xenobiotica; 2007 Feb; 37(2):139-54. PubMed ID: 17484517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of human cytochrome P450 3A4 in the metabolism of DA-8159, a new erectogenic.
    Ji HY; Lee HW; Kim HH; Kim DS; Yoo M; Kim WB; Lee HS
    Xenobiotica; 2004; 34(11-12):973-82. PubMed ID: 15801542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of human liver microsomes in metabolism-based drug-drug interactions: in vitro-in vivo correlations and the Abbott Laboratories experience.
    Rodrigues AD; Wong SL
    Adv Pharmacol; 1997; 43():65-101. PubMed ID: 9342173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.